Hood River Capital Management LLC Tg Therapeutics, Inc. Transaction History
Hood River Capital Management LLC
- $4.09 Billion
- Q2 2024
A detailed history of Hood River Capital Management LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Hood River Capital Management LLC holds 1,572,929 shares of TGTX stock, worth $37.5 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
1,572,929
Previous 1,474,037
6.71%
Holding current value
$37.5 Million
Previous $22.4 Million
24.81%
% of portfolio
0.68%
Previous 0.57%
Shares
8 transactions
Others Institutions Holding TGTX
# of Institutions
287Shares Held
91.8MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$326 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$271 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$160 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$86.9 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$77.3 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.46B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...